Correction: The HDAC inhibitor, MPT0E028, enhances erlotinib induced cell death in EGFR-TKI-resistant NSCLC cells
M. -C Chen, C. -H Chen, J. -C Wang, A. -C Tsai, J. -P Liou, S. -L Pan, C. -M Teng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEconomic and Social Development
Correction to: Cell Death and Disease 10.1038/cddis.2013.330, published online 19 September 2013
In Figure 4e (Ac-tubulin) and Figure 5b (p-EGFR), the western blots were inadvertently misplaced during final figure preparation. The results have been confirmed by three replicates and the figures have been corrected accordingly. These corrections do not affect the results and conclusions of this study. We deeply apologize for any confusion or inconvenience that this may have caused. The original article has been corrected.
The original blots of three replicates for the correction of 4e:
Corrected figure 4:
The original blots of three replicates for the correction of 5b:
Corrected figure 5: